#CureSMA 2018 – Results of Phase 2 Test of Reldesemtiv in 70 SMA Patients Set for Release at Meeting
News
Results of an exploratory Phase 2 study evaluating the effectiveness of reldesemtiv (CK-2127107) for a first time in patients with spinal muscular atrophy (SMA) will be presented at the Cure SMA annual conference set ... Read more